Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 25th:
Forty Seven, Inc. : This clinical-stage immuno-oncology company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.
Forty Seven’s shares gained 10.8% over the last one month against the S&P 500’s rise of 4.6%. The company possesses a Momentum Score of B.
Genfit SA (GNFT - Free Report) : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.9% over the last 60 days.
Genfit’s shares gained 15.8% over the last one month. The company possesses a Momentum Score of A.
U.S. Physical Therapy, Inc. (USPH - Free Report) : This outpatient physical therapy clinics operator has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
U.S. Physical Therapy’s shares gained 7.3% over the last one month. The company possesses a Momentum Score of A.
SPX Corporation (SPXC - Free Report) : This infrastructure equipment supplier has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
SPX's shares gained 8.7% over the last one month. The company possesses a Momentum Score of B.
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
Radical New Technology Creates $12.3 Trillion Opportunity
Imagine buying Microsoft stock in the early days of personal computers… or Motorola after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors.
Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.
See the 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 25th:
Forty Seven, Inc. : This clinical-stage immuno-oncology company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.
Forty Seven’s shares gained 10.8% over the last one month against the S&P 500’s rise of 4.6%. The company possesses a Momentum Score of B.
Genfit SA (GNFT - Free Report) : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.9% over the last 60 days.
Genfit’s shares gained 15.8% over the last one month. The company possesses a Momentum Score of A.
U.S. Physical Therapy, Inc. (USPH - Free Report) : This outpatient physical therapy clinics operator has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
U.S. Physical Therapy’s shares gained 7.3% over the last one month. The company possesses a Momentum Score of A.
SPX Corporation (SPXC - Free Report) : This infrastructure equipment supplier has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
SPX's shares gained 8.7% over the last one month. The company possesses a Momentum Score of B.
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
Radical New Technology Creates $12.3 Trillion Opportunity
Imagine buying Microsoft stock in the early days of personal computers… or Motorola after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors.
Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.
See the 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on USPH - FREE
Get the latest research report on SPXC - FREE
Get the latest research report on GNFT - FREE